We see a future where sequencing generates more information from DNA and is achievable at far lower costs, bringing closer the day when advanced medicines, diagnostics and personalized treatments become a reality for all. Cambridge Epigenetix (CEGX) is a life sciences tools and analytics company that has created a technology platform delivering step changes in both the type of information that can be generated from DNA and the cost at which it is gathered.